Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 0.55 9.22%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Lineage Cell Therapeutics Operating Cycle 2011-2024 | LCTX

Annual Operating Cycle Lineage Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
91.1 4.85 K 7.91 K 0.8 2.49 K 272 322 71.3 85.7 215 82.3 46.5 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
7.91 K 0.8 1.37 K

Quarterly Operating Cycle Lineage Cell Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
7.73 10.1 26 - 30.7 8.19 8.99 - 14.7 8.57 444 2.06 K 42.6 - 28.2 62.2 19.3 - 3.91 1.62 - - 2.51 3.07 - - 9.05 6.71 - - 40.2 14.2 - - 16.8 49.5 82.8 131 139 30.1 147 142 202 31.5 152 133 131 33.8 65.7 95 292 19.7 280 209 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.06 K 1.62 125